Publication Date
| In 2025 | 0 |
| Since 2024 | 3 |
| Since 2021 (last 5 years) | 13 |
| Since 2016 (last 10 years) | 23 |
| Since 2006 (last 20 years) | 53 |
Descriptor
| Drug Therapy | 59 |
| Foreign Countries | 58 |
| Adults | 14 |
| Symptoms (Individual… | 11 |
| Behavior Problems | 10 |
| Outcomes of Treatment | 10 |
| Behavior Modification | 9 |
| Patients | 9 |
| Attention Deficit… | 8 |
| Children | 8 |
| Incidence | 8 |
| More ▼ | |
Source
Author
| Deb, Shoumitro | 4 |
| Baird, Gillian | 2 |
| Bernard, Sarah | 2 |
| Davis, Robert | 2 |
| Heaton, Paul | 2 |
| Kilmer, Beau | 2 |
| Limbu, Bharati | 2 |
| McNulty, Cliodna A. M. | 2 |
| Rabinovich, Lila | 2 |
| Rubin, Jennifer | 2 |
| Simonoff, Emily | 2 |
| More ▼ | |
Publication Type
| Journal Articles | 53 |
| Reports - Research | 42 |
| Reports - Evaluative | 11 |
| Reports - Descriptive | 5 |
| Information Analyses | 3 |
| Books | 1 |
| Opinion Papers | 1 |
| Tests/Questionnaires | 1 |
Education Level
| Higher Education | 5 |
| Postsecondary Education | 5 |
| Elementary Secondary Education | 3 |
| Secondary Education | 3 |
| Elementary Education | 2 |
| High Schools | 1 |
Audience
| Teachers | 1 |
Location
| United Kingdom | 59 |
| United States | 10 |
| Australia | 6 |
| Netherlands | 5 |
| Canada | 4 |
| Switzerland | 4 |
| Finland | 2 |
| France | 2 |
| Germany | 2 |
| New Zealand | 2 |
| Sweden | 2 |
| More ▼ | |
Laws, Policies, & Programs
Assessments and Surveys
| Conners Rating Scales | 2 |
| Aberrant Behavior Checklist | 1 |
| Conners Teacher Rating Scale | 1 |
| Flesch Reading Ease Formula | 1 |
| Peabody Picture Vocabulary… | 1 |
| Strengths and Difficulties… | 1 |
| Wechsler Preschool and… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkLaila Tanana; Asam Latif; Prasad S. Nishtala; Timothy F. Chen – Journal of Attention Disorders, 2024
Objective: This study aimed to compare the approval of medicines for attention deficit/hyperactivity disorder (ADHD) for pediatric patients across five countries. Method: A document analysis was completed, using the drug labeling for ADHD medicines from five countries; United Kingdom, Australia, New Zealand, Canada and United States (US).…
Descriptors: Medicine, Drug Therapy, Attention Deficit Hyperactivity Disorder, Merchandise Information
Deb, Shoumitro; Limbu, Bharati; Nancarrow, Tom; Gerrard, David; Shankar, Rohit – Journal of Applied Research in Intellectual Disabilities, 2023
Background: Overprescribing of off-licence psychotropic medications, particularly antipsychotics, for challenging behaviours in people with intellectual disabilities without a psychiatric disorder is a significant public health concern. In the United Kingdom, the National Health Service England launched an initiative in 2016, 'STopping…
Descriptors: Foreign Countries, Psychiatry, Experience, Adults
Laermans, P.; Morisse, F.; Lombardi, M.; Gérard, S.; Vandevelde, S.; de Kuijper, G.; Audenaert, K.; Claes, C. – International Journal of Developmental Disabilities, 2023
Introduction: Adults with intellectual disabilities have an increased vulnerability to mental health problems and challenging behaviour. In addition to psychotherapeutic or psychoeducational methods, off-label pharmacotherapy, is a commonly used treatment modality. Objective: The aim of this study was to establish evidence-based guideline…
Descriptors: Adults, Intellectual Disability, Drug Therapy, Behavior Problems
Beresford, Cathy J.; Kozlowska, Olga – Journal of Applied Research in Intellectual Disabilities, 2022
Background: People with intellectual disabilities are more likely to have diabetes and develop complications from it. Diabetes management is complex and insulin treatment in particular, people with intellectual disabilities may require additional support that is not always available. This review aimed to identify barriers and facilitators to…
Descriptors: Barriers, Affordances, Diabetes, Drug Therapy
Lucy Beasant; Alba Realpe; Sarah Douglas; Lorcan Kenny; Dheeraj Rai; Nicola Mills – Autism: The International Journal of Research and Practice, 2024
The purpose of this study is to explore the views of autistic adults on randomised controlled trials, specifically on processes such as randomisation and blinding, to understand the barriers and facilitators for recruiting autistic people to randomised controlled trials involving medications. We conducted one-to-one interviews with 49 autistic…
Descriptors: Autism Spectrum Disorders, Adults, Attitudes, Randomized Controlled Trials
Alexander Häge; Kenneth K. C. Man; Sarah K. Inglis; Jan Buitelaar; Sara Carucci; Marina Danckaerts; Ralf W. Dittmann; Bruno Falissard; Peter Garas; Chris Hollis; Kerstin Konrad; Hanna Kovshoff; Elizabeth Liddle; Suzanne McCarthy; Antje Neubert; Peter Nagy; Eric Rosenthal; Edmund J. S. Sonuga-Barke; Alessandro Zuddas; Ian C. K. Wong; David Coghill; Tobias Banaschewski; ADDUCE Consortium – Journal of Attention Disorders, 2024
Objective: Short-term RCTs have demonstrated that MPH-treatment significantly reduces ADHD-symptoms, but is also associated with adverse events, including sleep problems. However, data on long-term effects of MPH on sleep remain limited. Methods: We performed a 2-year naturalistic prospective pharmacovigilance multicentre study. Participants were…
Descriptors: Sleep, Barriers, Children, Adolescents
Download full textCristina Vilaplana Prieto – European Journal of Education (EJED), 2021
As the Sars-CoV2 pandemic continues to grow, researchers around the world are urgently seeking new treatments to prevent infection, cure those infected, or lessen the severity of the disease. Although there are several recently approved vaccines, clinical trials are underway to "re-use" drugs normally indicated for other diseases. This…
Descriptors: COVID-19, Pandemics, Pharmacy, Drug Therapy
Alfageh, Basmah H.; Man, Kenneth K. C.; Besag, Frank M. C.; Alhawassi, Tariq M.; Wong, Ian C. K.; Brauer, Ruth – Journal of Autism and Developmental Disorders, 2020
Autism spectrum disorder (ASD) is a lifelong disorder. In the UK, risperidone is the only psychotropic medication approved for the management of the behavioural symptoms that may accompany autism. This is a population-based study aimed to provide an evaluation of the changing trend in the incidence and prevalence of ASD and to analyse the pattern…
Descriptors: Autism, Pervasive Developmental Disorders, Drug Therapy, Behavior Problems
Hayes, Catherine; Eley, Charlotte; Brown, Carla; Syeda, Rowshonara; Verlander, Neville Q.; Hann, Magda; McNulty, Cliodna – Health Education Journal, 2021
Objective: e-Bug is a teaching resource that addresses the UK 5-year National Action Plan on antimicrobial resistance (AMR) that pledges to work with educators and local authorities to ensure young people understand infection prevention and control (IPC) and AMR. This study aimed to evaluate the effectiveness and acceptability of the e-Bug…
Descriptors: Knowledge Level, Self Esteem, Prevention, Microbiology
Deb, Shoumitro; Limbu, Bharati; Unwin, Gemma L.; Weaver, Tim – Journal of Mental Health Research in Intellectual Disabilities, 2023
Background: Overmedication of people with intellectual disabilities, particularly when psychotropic medications are used for challenging behavior (CB) in the absence of a psychiatric disorder, is a significant public health concern. Support staff play a pivotal role in influencing the prescribing process. Staff views and attitudes toward…
Descriptors: Drug Therapy, Intellectual Disability, Behavior Problems, Caregiver Attitudes
Davies, Bronwen; Silver, Jade; Josham, Scarlett; Grist, Emma; Jones, Lewis; Francis, Nicky; Truelove, Cerys; Shindler, Matthew; Jones, Sian; Gwatkin, Alice – Journal of Intellectual Disabilities, 2021
This study evaluates the implementation of Safewards on an assessment and treatment unit (ATU) for people with an intellectual disability. There are no previous studies evaluating this model in this context and previous research has focused largely on acute mental health services. The 'Patient-Staff Conflict Shift Report' was used at baseline for…
Descriptors: Intellectual Disability, Intervention, Hospitals, Conflict
McCullagh, John F. – School Science Review, 2019
The physical and chemical properties of Milk of Magnesia provide examples of chemical concepts and opportunities for investigative practical work for secondary chemistry students of all ages. Basing the lesson on the contents of that familiar blue bottle, which is probably lurking somewhere in a cupboard in most households, also showcases the role…
Descriptors: Biochemistry, Science Instruction, Secondary School Students, Pharmacy
Malda Castillo, Javier; Smith, Ian; Morris, Lucy; Perez-Algorta, Guillermo – Journal of Applied Research in Intellectual Disabilities, 2018
Background: The issue of violence in secure services has long been recognized both in the UK and worldwide. However, there is currently scarce literature available about violence within learning disability (LD) secure settings. Methods: Secondary data analysis was conducted on violent incidents, using information routinely collected by the staff…
Descriptors: Violence, Learning Disabilities, Residential Institutions, Drug Therapy
Clarke, Amy L.; Sowemimo, Tamilore; Jones, Annie S. K.; Rangaka, Molebogeng X.; Horne, Rob – Health Education Journal, 2021
Objective: People with latent tuberculosis infection (LTBI) are required to make complex treatment decisions, which require an understanding of personal risk and associated benefits. However, many people with LTBI in the United Kingdom are at risk of low health literacy and can also experience language barriers, which can affect decision making.…
Descriptors: Patient Education, Diseases, Readability, Readability Formulas
Benham-Clarke, Simon; Ford, Tamsin; Mitchell, Siobhan B.; Price, Anna; Newlove-Delgado, Tamsin; Blake, Sharon; Eke, Helen; Moore, Darren A.; Emma Russell, Abigail; Janssens, Astrid – Emotional & Behavioural Difficulties, 2021
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental condition. As such most schools, Further Education colleges, vocational training and Higher Education settings will need to support affected children and young people. When young people who require ongoing treatment for ADHD are around 18 years of age, they must…
Descriptors: Attention Deficit Hyperactivity Disorder, Health Services, Access to Health Care, Young Adults
